PubMed · 6519183
Kynuramine: high affinity for [3H]tryptamine binding sites.
Abstract
Kynuramine, an endogenously occurring metabolite of L-tryptophan, was found to displace [3H]tryptamine from its high affinity binding sites in rat brain cortex with an inhibition constant (Ki) of 28 nM. Kynuramine exhibited structural specificity and considerable selectivity, compared with its affinity for serotonergic, adrenergic and benzodiazepine recognition sites. This novel finding opens-up the possibility that kynuramine may exert physiological actions via the putative tryptamine receptor.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
K G Charlton, T D Johnson, R W Maurice, D E Clarke. 1984-11-27. Kynuramine: high affinity for [3H]tryptamine binding sites.. https://doi.org/10.1016/0014-2999(84)90076-1
Cite the original work for its findings. Save a collection to share your selection of sources.